Summary:

The current invention relates to a diagnostic tool and method for detecting SARS-Cov-2 virus in  its eye, including: a preliminary order or includes a primary monoclonsic immune body and a  secondary monoclonsic immune body for the specialized association with or parts of the N or S virus sphage proteins whereas: The primary ampere or primary immune body is associated with  an activated cellulose holder, and the secondary ampere or secondary immune body is  associated with activated colored nano granules where the cellulose holder (the first platform) is  activated by the order by modifying one end of the order by adding amino totals to it. While the  cellulose carrier is activated by the immune body’s association without amino modification, the  cellulose carrier is modified by an organic bi-carboxyl compound, glutamic Acid, and then the modified primary orphan reactor or the unmodified primary immune body with the activated  cellulose carrier. The activation of nanoparticles (platform II) begins with the addition of carboxy  totals and then their reactor with a two-secretary organic compound, Lysine Lisine and then the modified secondary single reactor or the unmodified secondary immune body with activated  nanoparticles.

Inventor Name: Dr. Khalid Abu Salah, Moayad Alhariri and Dr. Ibrahim Bushnak

Date of Issue: 13, April 2022